73 related articles for article (PubMed ID: 18640288)
1. Chlamydia pneumoniae infection results in generalized bone loss in mice.
Bailey L; Engström P; Nordström A; Bergström S; Waldenström A; Nordström P
Microbes Infect; 2008; 10(10-11):1175-81. PubMed ID: 18640288
[TBL] [Abstract][Full Text] [Related]
2. Chlamydia pneumoniae and atherosclerosis.
Campbell LA; Kuo CC
Semin Respir Infect; 2003 Mar; 18(1):48-54. PubMed ID: 12652454
[TBL] [Abstract][Full Text] [Related]
3. Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae.
Rizzo A; Di Domenico M; Carratelli CR; Mazzola N; Paolillo R
Cytokine; 2011 Nov; 56(2):450-7. PubMed ID: 21803599
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha plays a role in the acceleration of atherosclerosis by Chlamydia pneumoniae in mice.
Campbell LA; Nosaka T; Rosenfeld ME; Yaraei K; Kuo CC
Infect Immun; 2005 May; 73(5):3164-5. PubMed ID: 15845526
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia pneumoniae and osteoporosis-associated bone loss: a new risk factor?
Di Pietro M; Schiavoni G; Sessa V; Pallotta F; Costanzo G; Sessa R
Osteoporos Int; 2013 May; 24(5):1677-82. PubMed ID: 23160916
[TBL] [Abstract][Full Text] [Related]
6. Acute Chlamydia pneumoniae reinfection accelerates the development of insulin resistance and diabetes in obese C57BL/6 mice.
Wang C; Gao D; Kaltenboeck B
J Infect Dis; 2009 Jul; 200(2):279-87. PubMed ID: 19508161
[TBL] [Abstract][Full Text] [Related]
7. Targeting of the osteoclastogenic RANKL-RANK axis prevents osteoporotic bone loss and soft tissue calcification in coxsackievirus B3-infected mice.
Lee K; Kim H; Park HS; Kim KJ; Song H; Shin HI; Kim HS; Seo D; Kook H; Ko JH; Jeong D
J Immunol; 2013 Feb; 190(4):1623-30. PubMed ID: 23303667
[TBL] [Abstract][Full Text] [Related]
8. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.
Rothstein NM; Quinn TC; Madico G; Gaydos CA; Lowenstein CJ
J Infect Dis; 2001 Jan; 183(2):232-238. PubMed ID: 11120929
[TBL] [Abstract][Full Text] [Related]
9. Depletion of Intestinal Microbiome Partially Rescues Bone Loss in Sickle Cell Disease Male Mice.
Tavakoli S; Xiao L
Sci Rep; 2019 Jun; 9(1):8659. PubMed ID: 31209247
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and atrial fibrillation: is Chlamydia pneumoniae a candidate pathogen of atrial fibrillation?
Tang RB; Dong JZ; Liu XP; Ma CS
Med Hypotheses; 2006; 67(3):462-6. PubMed ID: 16793213
[TBL] [Abstract][Full Text] [Related]
11. Choroidal neovascularization enhanced by Chlamydia pneumoniae via Toll-like receptor 2 in the retinal pigment epithelium.
Fujimoto T; Sonoda KH; Hijioka K; Sato K; Takeda A; Hasegawa E; Oshima Y; Ishibashi T
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4694-702. PubMed ID: 20393111
[TBL] [Abstract][Full Text] [Related]
12. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies.
Tyagi AM; Mansoori MN; Srivastava K; Khan MP; Kureel J; Dixit M; Shukla P; Trivedi R; Chattopadhyay N; Singh D
J Bone Miner Res; 2014 Sep; 29(9):1981-92. PubMed ID: 24677326
[TBL] [Abstract][Full Text] [Related]
13. Effect of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, on experimental Chlamydophila pneumoniae infection.
Caronzolo D; Lucini V; Pannacci M; Grosso S; Kieffer N; Bello L; Bikfalvi A; Scaglione F
Antimicrob Agents Chemother; 2006 Oct; 50(10):3277-82. PubMed ID: 17005805
[TBL] [Abstract][Full Text] [Related]
14. Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice.
Little CS; Bowe A; Lin R; Litsky J; Fogel RM; Balin BJ; Fresa-Dillon KL
Infect Immun; 2005 Mar; 73(3):1723-34. PubMed ID: 15731073
[TBL] [Abstract][Full Text] [Related]
15. Higher titers of anti-Chlamydia pneumoniae IgG in diabetic retinopathy: a cross-sectional study.
Banaee T; Daneshvar Kakhki R; Abrishami M; Mahmoudi M; Farzadnia M
Diabetes Metab Res Rev; 2015 Feb; 31(2):168-74. PubMed ID: 25066224
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia pneumoniae infection enhances cellular proliferation and reduces steroid responsiveness of human peripheral blood mononuclear cells via a tumor necrosis factor-alpha-dependent pathway.
Cho YS; Kim TB; Lee TH; Moon KA; Lee J; Kim YK; Lee KY; Moon HB
Clin Exp Allergy; 2005 Dec; 35(12):1625-31. PubMed ID: 16393329
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of osteoclastogenesis by osteoblast-like cells genetically engineered to produce interleukin-10.
Fujioka K; Kishida T; Ejima A; Yamamoto K; Fujii W; Murakami K; Seno T; Yamamoto A; Kohno M; Oda R; Yamamoto T; Fujiwara H; Kawahito Y; Mazda O
Biochem Biophys Res Commun; 2015 Jan; 456(3):785-91. PubMed ID: 25514036
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory responses following Chlamydia pneumoniae infection of glial cells.
Boelen E; Steinbusch HW; Pronk I; Grauls G; Rennert P; Bailly V; Bruggeman CA; Stassen FR
Eur J Neurosci; 2007 Feb; 25(3):753-60. PubMed ID: 17313571
[TBL] [Abstract][Full Text] [Related]
19. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline suppresses Chlamydia pneumoniae-mediated increases in ongoing immunoglobulin E and interleukin-4 responses by peripheral blood mononuclear cells of patients with allergic asthma.
Dzhindzhikhashvili MS; Joks R; Smith-Norowitz T; Durkin HG; Chotikanatis K; Estrella E; Hammerschlag MR; Kohlhoff SA
J Antimicrob Chemother; 2013 Oct; 68(10):2363-8. PubMed ID: 23749949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
